Ablative therapies for renal tumors.

Area of Science:

• Nephrology
• Oncology
• Minimally Invasive Surgery

Background:

• Incidental kidney masses are increasingly diagnosed due to advanced imaging, now representing the majority of renal tumors.
• Renal ablative therapy is gaining importance for managing renal tumors, especially in patients with borderline renal impairment.
• This therapy utilizes extreme temperatures (heat or cold) to induce cancer cell death.

Purpose of the Study:

• To review the emerging 5-year outcomes of renal ablative therapies.
• To highlight the significance of renal biopsy during ablation for accurate diagnosis.
• To emphasize the utility of real-time temperature monitoring in radiofrequency ablation.

Main Methods:

• Review of emerging 5-year data for radiofrequency ablation and cryoablation.
• Discussion of the importance of concurrent renal biopsy for tissue diagnosis.
• Emphasis on real-time temperature monitoring during radiofrequency ablation.

Main Results:

• Five-year results for both radiofrequency ablation and cryoablation are becoming available.
• Renal biopsy at the time of ablation is crucial for establishing a definitive tissue diagnosis.
• Real-time temperature monitoring aids in ensuring the effectiveness of radiofrequency ablation.

Conclusions:

• Renal ablative therapies are important treatment options for incidentally discovered renal tumors, particularly in patients with compromised kidney function.
• Accurate tissue diagnosis via biopsy and precise procedural monitoring are key to successful renal ablation outcomes.